American Century Companies’s BioTelemetry, Inc. BEAT Stock Holding History

American Century Companies’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-9,112	Closed	-$657K	–	2283
2020 Q4	$657K	Sell	9,112 -3,875	-30%	-$203K	﹤0.01%	1435
2020 Q3	$592K	Buy	12,987 +4,395	+51%	+$184K	﹤0.01%	1280
2020 Q2	$388K	Sell	8,592 -8,838	-51%	-$396K	﹤0.01%	1368
2020 Q1	$671K	Buy	+17,430	New	+$802K	﹤0.01%	1092

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

American Century Companies's BEAT Position: Q1 2021 in Review

American Century Companies sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 9,112 shares — an estimated $657K sold.

American Century Companies first reported a position in BEAT in Q1 2020 and held it in 4 quarters. The position peaked at $671K in Q1 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

American Century Companies reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
American Century Companies sold 9,112 BioTelemetry, Inc. shares in Q1 2021, an estimated $657K.
American Century Companies first reported a position in BioTelemetry, Inc. in Q1 2020 and held it in 4 quarters.
American Century Companies's BioTelemetry, Inc. position peaked at $671K in Q1 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on American Century Companies's 13F filing for Q1 2021, filed 14 May 2021.